
Method developed to test new Parkinson's therapies
Aug. 21 (UPI) -- Researchers have developed a new tool that can evaluate new therapies for Parkinson's disease, which they say could lead to quicker development of drugs to treat the neurological condition. In a test of mice, the new model induces the biology of a disease-causing gene rather than the symptoms. Researchers at the University of British Columbia's Djavad Mowafaghian Center for Brain Health published their findings Tuesday in the journal Nature Parkinson's Disease. Parkinson's disease is a chronic, degenerative neurological disorder that affects the body's motor system, causing people to shake and have difficulty with movements. In the United States, about 10 million people have the illness, according to the Parkinson's Disease Foundation. Many patients have mutations in a ge...